Schedule 13G ownership disclosure

XTL BIOPHARMACEUTICALS LTD

Security class unavailable · CUSIP: 98386D109

Event date: 2015-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
666,666
Percent of class
4.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000054
Form type
SC 13G
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Apr 02, 2015
Reporting period
Mar 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub